Atlas Trials

Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)

Clinical trial NCT03771378 · UNKNOWN

Trial details

NCT number
NCT03771378
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Primary Immune Thrombocytopenia
Start date
2019-01-16
Primary completion
2020-05-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.